CoraLite® Plus 647-conjugated Desmin Recombinant monoclonal antibody

Desmin Uni-rAb® Recombinant Antibody for IF-P
Cat No. CL647-82748

产品说明书

CloneNo. 1D21

宿主/亚型

Rabbit / IgG

种属反应性

human, mouse, rat, pig

应用

IF-P

1D21, DES

缓冲液配方:  PBS and Azide
PBS and Azide
规格价格库存


经过测试的应用

Positive IF-P detected inmouse heart tissue
Planning an IHC experiment? We recommend our IHCeasy Desmin Ready-To-Use IHC Kit. Desmin primary antibody included.
For other applications, we recommend the unconjugated version of this antibody, 82748-1-PBS

推荐稀释比

应用推荐稀释比
Immunofluorescence (IF)-PIF-P : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

CL647-82748 targets Desmin in IF-P applications and shows reactivity with human, mouse, rat, pig samples.

经测试应用 IF-P Application Description
经测试反应性 human, mouse, rat, pig
免疫原

CatNo: Ag9742

Product name:

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: of

Sequence:

种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 desmin
别名 1D21, DES
计算分子量 470 aa, 54 kDa
观测分子量 53 kDa
GenBank蛋白编号BC032116
基因名称 Desmin
Gene ID (NCBI) 1674
偶联类型 CoraLite® Plus 647 Fluorescent Dye
最大激发/发射波长654 nm / 674 nm
形式Liquid
纯化方式Protein A purification
UNIPROT IDP17661
储存缓冲液 PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
储存条件Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

Desmin is the main intermediate filament protein in skeletal and cardiac muscle cells and is essential for both the structural integrity and the survival of muscle cells. As an abundant muscle-specific protein, desmin has been widely used as a marker of muscle derived tumors. Anti-desmin is also valuable in the differential diagnosis of tumors of uncertain origin.

实验方案

Product Specific Protocols
IF protocol for CL Plus 647 Desmin antibody CL647-82748Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...